| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.64e-06 | 127 | 57 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 3.67e-06 | 37 | 57 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 5.58e-05 | 614 | 57 | 9 | GO:0140657 | |
| GeneOntologyMolecularFunction | helicase activity | 8.75e-05 | 158 | 57 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 9.98e-05 | 262 | 57 | 6 | GO:0140097 | |
| GeneOntologyMolecularFunction | chromatin-protein adaptor activity | 2.18e-04 | 41 | 57 | 3 | GO:0140463 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 3.01e-04 | 206 | 57 | 5 | GO:0140030 | |
| GeneOntologyMolecularFunction | histone binding | 9.45e-04 | 265 | 57 | 5 | GO:0042393 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | TCERG1L KDM5A BAZ2A ANKRD1 MPHOSPH8 ICE1 CHD1L TRDN MTDH SEPTIN6 RAD50 | 1.38e-03 | 1356 | 57 | 11 | GO:0060090 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TCERG1L KDM5A BAZ2A ANKRD1 MPHOSPH8 ICE1 CHD1L TRDN MTDH RAD50 | 1.50e-03 | 1160 | 57 | 10 | GO:0030674 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 1.52e-03 | 775 | 57 | 8 | GO:0017111 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.57e-03 | 441 | 57 | 6 | GO:0016887 | |
| GeneOntologyMolecularFunction | methylated histone binding | 1.91e-03 | 86 | 57 | 3 | GO:0035064 | |
| GeneOntologyMolecularFunction | SMAD binding | 1.91e-03 | 86 | 57 | 3 | GO:0046332 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 2.04e-03 | 88 | 57 | 3 | GO:0140034 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 2.31e-03 | 645 | 57 | 7 | GO:0140640 | |
| GeneOntologyMolecularFunction | R-SMAD binding | 2.49e-03 | 26 | 57 | 2 | GO:0070412 | |
| GeneOntologyMolecularFunction | histone reader activity | 2.49e-03 | 26 | 57 | 2 | GO:0140566 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 2.50e-03 | 839 | 57 | 8 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 2.52e-03 | 840 | 57 | 8 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 2.52e-03 | 840 | 57 | 8 | GO:0016818 | |
| GeneOntologyMolecularFunction | actin monomer binding | 3.09e-03 | 29 | 57 | 2 | GO:0003785 | |
| GeneOntologyMolecularFunction | chromatin binding | 4.89e-03 | 739 | 57 | 7 | GO:0003682 | |
| GeneOntologyBiologicalProcess | replication fork processing | 1.20e-05 | 52 | 56 | 4 | GO:0031297 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication maintenance of fidelity | 2.12e-05 | 60 | 56 | 4 | GO:0045005 | |
| GeneOntologyCellularComponent | heterochromatin | 1.55e-04 | 101 | 56 | 4 | GO:0000792 | |
| GeneOntologyCellularComponent | cleavage furrow | 5.87e-04 | 61 | 56 | 3 | GO:0032154 | |
| GeneOntologyCellularComponent | ISWI-type complex | 6.28e-04 | 14 | 56 | 2 | GO:0031010 | |
| HumanPheno | Cerebral artery stenosis | 1.80e-05 | 3 | 13 | 2 | HP:0012492 | |
| HumanPheno | Functional abnormality of the inner ear | 2.62e-05 | 1077 | 13 | 10 | HP:0011389 | |
| HumanPheno | Abnormality of the inner ear | 3.24e-05 | 1102 | 13 | 10 | HP:0000359 | |
| Domain | MIM/ABBA | 7.60e-06 | 2 | 52 | 2 | IPR030127 | |
| Domain | WHIM1 | 7.56e-05 | 5 | 52 | 2 | PF15612 | |
| Domain | IMD | 7.56e-05 | 5 | 52 | 2 | PS51338 | |
| Domain | WHIM1_dom | 7.56e-05 | 5 | 52 | 2 | IPR028942 | |
| Domain | SNF2_N | 9.54e-05 | 32 | 52 | 3 | IPR000330 | |
| Domain | SNF2_N | 9.54e-05 | 32 | 52 | 3 | PF00176 | |
| Domain | DDT | 1.13e-04 | 6 | 52 | 2 | PS50827 | |
| Domain | IMD | 1.13e-04 | 6 | 52 | 2 | PF08397 | |
| Domain | ZF_PHD_2 | 1.41e-04 | 95 | 52 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 1.47e-04 | 96 | 52 | 4 | PS01359 | |
| Domain | Helicase_C | 2.23e-04 | 107 | 52 | 4 | PF00271 | |
| Domain | HELICc | 2.23e-04 | 107 | 52 | 4 | SM00490 | |
| Domain | Helicase_C | 2.31e-04 | 108 | 52 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 2.40e-04 | 109 | 52 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.40e-04 | 109 | 52 | 4 | PS51192 | |
| Domain | DEXDc | 2.40e-04 | 109 | 52 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 2.48e-04 | 110 | 52 | 4 | IPR014001 | |
| Domain | I-BAR_dom | 5.82e-04 | 13 | 52 | 2 | IPR013606 | |
| Domain | Znf_FYVE_PHD | 7.44e-04 | 147 | 52 | 4 | IPR011011 | |
| Domain | PHD | 1.19e-03 | 75 | 52 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 1.39e-03 | 79 | 52 | 3 | IPR019787 | |
| Domain | - | 1.49e-03 | 449 | 52 | 6 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 1.67e-03 | 459 | 52 | 6 | IPR013083 | |
| Domain | PHD | 1.95e-03 | 89 | 52 | 3 | SM00249 | |
| Domain | Chromo_domain | 2.02e-03 | 24 | 52 | 2 | IPR023780 | |
| Domain | WH2 | 2.02e-03 | 24 | 52 | 2 | PS51082 | |
| Domain | Znf_PHD | 2.08e-03 | 91 | 52 | 3 | IPR001965 | |
| Domain | P-loop_NTPase | 2.23e-03 | 848 | 52 | 8 | IPR027417 | |
| Domain | Chromo | 2.37e-03 | 26 | 52 | 2 | PF00385 | |
| Domain | AT_hook | 2.55e-03 | 27 | 52 | 2 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 2.55e-03 | 27 | 52 | 2 | IPR017956 | |
| Domain | CHROMO_1 | 2.74e-03 | 28 | 52 | 2 | PS00598 | |
| Domain | CHROMO_2 | 2.74e-03 | 28 | 52 | 2 | PS50013 | |
| Domain | Chromodomain-like | 3.57e-03 | 32 | 52 | 2 | IPR016197 | |
| Domain | Chromo/shadow_dom | 3.80e-03 | 33 | 52 | 2 | IPR000953 | |
| Domain | CHROMO | 3.80e-03 | 33 | 52 | 2 | SM00298 | |
| Domain | - | 4.41e-03 | 746 | 52 | 7 | 3.40.50.300 | |
| Pubmed | FAM133B RALA PARP1 MYH11 UTP18 TCERG1L ATRX KDM5A FAM186A RSF1 SYCP1 DUOX2 BOD1L1 MPHOSPH8 LSM14A DIAPH3 CEP57 TRDN MTDH LETM1 TOP2B ESF1 DOP1A UTP14C | 1.12e-18 | 1442 | 57 | 24 | 35575683 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NELFE FAM193B PARP1 ATRX BAZ2A RSF1 BOD1L1 LSM14A ICE1 MTDH DEPDC1B TOP2B ESF1 RAD50 | 2.43e-10 | 934 | 57 | 14 | 33916271 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RALA PARP1 UTP18 NF1 ATRX RBM19 DUOX2 BOD1L1 MPHOSPH8 MTDH DDX27 LETM1 TOP2B ESF1 RAD50 | 6.24e-09 | 1425 | 57 | 15 | 30948266 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.04e-08 | 283 | 57 | 8 | 30585729 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NELFE PARP1 ATRX BAZ2A RBM19 RSF1 BOD1L1 MPHOSPH8 ICE1 MTDH TOP2B ESF1 | 3.85e-08 | 954 | 57 | 12 | 36373674 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NELFE UTP18 NF1 ATRX MYCBP2 KDM5A BAZ2A CPSF2 TOP2B ESF1 RAD50 | 4.49e-08 | 774 | 57 | 11 | 15302935 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PARP1 ATRX KDM5A BAZ2A RSF1 CHD9 BOD1L1 MPHOSPH8 CHD1L TOP2B | 5.11e-08 | 608 | 57 | 10 | 36089195 |
| Pubmed | NELFE PARP1 ATRX RSF1 CHD9 BOD1L1 MPHOSPH8 CHD1L CPSF2 TOP2B ESF1 RAD50 | 7.47e-08 | 1014 | 57 | 12 | 32416067 | |
| Pubmed | PARP1 UTP18 ATRX MYCBP2 BAZ2A CCDC18 DIAPH3 RRM1 MTDH DDX27 DEPDC1B LETM1 TOP2B ESF1 | 8.79e-08 | 1487 | 57 | 14 | 33957083 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 1.02e-07 | 349 | 57 | 8 | 25665578 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NELFE NF1 ARHGEF28 MYCBP2 KDM5A CCDC18 BOD1L1 SH3RF3 DEPDC1B DOP1A MTSS2 | 1.31e-07 | 861 | 57 | 11 | 36931259 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PARP1 UTP18 NF1 MYCBP2 BAZ2A RBM19 RSF1 CHD1L RRM1 DDX27 TOP2B ESF1 RAD50 | 2.19e-07 | 1353 | 57 | 13 | 29467282 |
| Pubmed | NELFE RALA PARP1 MYH11 KDM5A RBM19 LSM14A CHD1L CPSF2 PIPSL MTDH DDX27 SEPTIN6 | 2.55e-07 | 1371 | 57 | 13 | 36244648 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NELFE PARP1 UTP18 RBM19 ANKRD1 BOD1L1 MPHOSPH8 DDX27 TOP2B ESF1 RAD50 | 5.19e-07 | 989 | 57 | 11 | 36424410 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | PARP1 UTP18 TBRG1 ATRX KDM5A BAZ2A MPHOSPH8 CHD1L CPSF2 MTDH TOP2B RAD50 | 1.00e-06 | 1294 | 57 | 12 | 30804502 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | PARP1 MYH11 SLC13A4 ATP6V1D BOD1L1 PIPSL RRM1 SEPTIN6 DOP1A RAD50 | 1.07e-06 | 847 | 57 | 10 | 35235311 |
| Pubmed | 1.19e-06 | 332 | 57 | 7 | 25693804 | ||
| Pubmed | 2.37e-06 | 234 | 57 | 6 | 36243803 | ||
| Pubmed | Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation. | 2.64e-06 | 2 | 57 | 2 | 27256882 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 23132853 | ||
| Pubmed | The chromatin remodeler ALC1 underlies resistance to PARP inhibitor treatment. | 2.64e-06 | 2 | 57 | 2 | 33355125 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 26201266 | ||
| Pubmed | Multiple roles for PARP1 in ALC1-dependent nucleosome remodeling. | 2.64e-06 | 2 | 57 | 2 | 34465625 | |
| Pubmed | CHD1L: a new candidate gene for congenital anomalies of the kidneys and urinary tract (CAKUT). | 2.64e-06 | 2 | 57 | 2 | 22146311 | |
| Pubmed | 3.55e-06 | 251 | 57 | 6 | 31076518 | ||
| Pubmed | 5.51e-06 | 419 | 57 | 7 | 15635413 | ||
| Pubmed | Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus. | 6.48e-06 | 159 | 57 | 5 | 34578187 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 7.58e-06 | 440 | 57 | 7 | 34244565 | |
| Pubmed | Ral overactivation in malignant peripheral nerve sheath tumors. | 7.91e-06 | 3 | 57 | 2 | 19414599 | |
| Pubmed | PARP1 promotes nucleotide excision repair through DDB2 stabilization and recruitment of ALC1. | 7.91e-06 | 3 | 57 | 2 | 23045548 | |
| Pubmed | Serine ADP-ribosylation marks nucleosomes for ALC1-dependent chromatin remodeling. | 7.91e-06 | 3 | 57 | 2 | 34874266 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 26876283 | ||
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 7.95e-06 | 289 | 57 | 6 | 23752268 | |
| Pubmed | 8.97e-06 | 170 | 57 | 5 | 15057823 | ||
| Pubmed | 1.06e-05 | 26 | 57 | 3 | 35920200 | ||
| Pubmed | 1.09e-05 | 653 | 57 | 8 | 33742100 | ||
| Pubmed | 1.09e-05 | 653 | 57 | 8 | 22586326 | ||
| Pubmed | 1.25e-05 | 86 | 57 | 4 | 37253089 | ||
| Pubmed | 1.46e-05 | 188 | 57 | 5 | 29721183 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 33053171 | ||
| Pubmed | ABBA regulates plasma-membrane and actin dynamics to promote radial glia extension. | 1.58e-05 | 4 | 57 | 2 | 18413296 | |
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 14752106 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.74e-05 | 332 | 57 | 6 | 32786267 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 2.28e-05 | 724 | 57 | 8 | 36232890 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 2.37e-05 | 208 | 57 | 5 | 33230847 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALA ATRX MYCBP2 CHD9 BOD1L1 LSM14A CHD1L ANKRD12 SH3RF3 SEPTIN6 DOP1A | 2.56e-05 | 1489 | 57 | 11 | 28611215 |
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 21228215 | ||
| Pubmed | ATRX dysfunction induces replication defects in primary mouse cells. | 2.63e-05 | 5 | 57 | 2 | 24651726 | |
| Pubmed | FAM133B ATRX KDM5A BAZ2A RBM19 MPHOSPH8 LSM14A ICE1 CPSF2 DDX27 ESF1 | 2.69e-05 | 1497 | 57 | 11 | 31527615 | |
| Pubmed | 3.14e-05 | 549 | 57 | 7 | 38280479 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 3.19e-05 | 759 | 57 | 8 | 35915203 | |
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 19181665 | ||
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 19450526 | ||
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 23926104 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 4.06e-05 | 1024 | 57 | 9 | 24711643 | |
| Pubmed | Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates. | 4.26e-05 | 41 | 57 | 3 | 15561718 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 4.54e-05 | 582 | 57 | 7 | 20467437 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 4.91e-05 | 807 | 57 | 8 | 22681889 | |
| Pubmed | An Interaction Network of the Human SEPT9 Established by Quantitative Mass Spectrometry. | 4.92e-05 | 43 | 57 | 3 | 30975701 | |
| Pubmed | 5.00e-05 | 591 | 57 | 7 | 15231748 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | FAM133B PARP1 UTP18 KDM5A BAZ2A CHD1L CPSF2 MTDH DDX27 TOP2B | 5.03e-05 | 1318 | 57 | 10 | 30463901 |
| Pubmed | A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription. | 5.51e-05 | 7 | 57 | 2 | 16794079 | |
| Pubmed | Topoisomerase II regulates the maintenance of DNA methylation. | 5.51e-05 | 7 | 57 | 2 | 25451918 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 5.79e-05 | 605 | 57 | 7 | 28977666 | |
| Pubmed | 6.29e-05 | 418 | 57 | 6 | 34709266 | ||
| Pubmed | 6.30e-05 | 1084 | 57 | 9 | 11544199 | ||
| Pubmed | 6.42e-05 | 615 | 57 | 7 | 31048545 | ||
| Pubmed | 7.19e-05 | 1103 | 57 | 9 | 34189442 | ||
| Pubmed | HIV-1 Vpr modulates macrophage metabolic pathways: a SILAC-based quantitative analysis. | 7.31e-05 | 135 | 57 | 4 | 23874603 | |
| Pubmed | 7.34e-05 | 8 | 57 | 2 | 28345663 | ||
| Pubmed | The human Rap1 protein complex and modulation of telomere length. | 7.34e-05 | 8 | 57 | 2 | 15100233 | |
| Pubmed | 7.34e-05 | 8 | 57 | 2 | 16115198 | ||
| Pubmed | Hypermutation of immunoglobulin genes in memory B cells of DNA repair-deficient mice. | 7.34e-05 | 8 | 57 | 2 | 9607915 | |
| Pubmed | 8.77e-05 | 274 | 57 | 5 | 34244482 | ||
| Pubmed | 9.43e-05 | 9 | 57 | 2 | 24725430 | ||
| Pubmed | The male germline-specific protein MAPS is indispensable for pachynema progression and fertility. | 9.43e-05 | 9 | 57 | 2 | 33602822 | |
| Pubmed | Intercellular bridges coordinate the transition from pluripotency to meiosis in mouse fetal oocytes. | 9.43e-05 | 9 | 57 | 2 | 33827806 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 1.04e-04 | 148 | 57 | 4 | 32538781 | |
| Pubmed | 1.18e-04 | 10 | 57 | 2 | 30289439 | ||
| Pubmed | A role of DNA-PK for the metabolic gene regulation in response to insulin. | 1.18e-04 | 10 | 57 | 2 | 19303849 | |
| Pubmed | 1.39e-04 | 483 | 57 | 6 | 36912080 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | PARP1 UTP18 MYCBP2 BAZ2A DIAPH3 MTDH DDX27 DEPDC1B LETM1 ESF1 | 1.43e-04 | 1496 | 57 | 10 | 32877691 |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 1.45e-04 | 701 | 57 | 7 | 30196744 | |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 1.51e-04 | 163 | 57 | 4 | 22113938 | |
| Pubmed | 1.54e-04 | 708 | 57 | 7 | 39231216 | ||
| Pubmed | 1.55e-04 | 493 | 57 | 6 | 15368895 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 1.63e-04 | 313 | 57 | 5 | 38270169 | |
| Pubmed | 1.67e-04 | 963 | 57 | 8 | 28671696 | ||
| Pubmed | ATRX directs binding of PRC2 to Xist RNA and Polycomb targets. | 1.72e-04 | 12 | 57 | 2 | 25417162 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 1.93e-04 | 1257 | 57 | 9 | 36526897 | |
| Pubmed | 2.03e-04 | 13 | 57 | 2 | 34912016 | ||
| Pubmed | 2.03e-04 | 13 | 57 | 2 | 19064565 | ||
| Pubmed | BMP signaling controls formation of a primordial germ cell niche within the early genital ridges. | 2.03e-04 | 13 | 57 | 2 | 20417197 | |
| Pubmed | 2.03e-04 | 13 | 57 | 2 | 21406566 | ||
| Pubmed | 2.08e-04 | 177 | 57 | 4 | 26206133 | ||
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 2.17e-04 | 179 | 57 | 4 | 36261009 | |
| Pubmed | 2.30e-04 | 72 | 57 | 3 | 31248990 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 2.36e-04 | 533 | 57 | 6 | 30554943 | |
| Pubmed | SIX1 acts synergistically with TBX18 in mediating ureteral smooth muscle formation. | 2.37e-04 | 14 | 57 | 2 | 20110314 | |
| Pubmed | 2.39e-04 | 340 | 57 | 5 | 29478914 | ||
| Interaction | NAA40 interactions | NELFE FAM193B PARP1 ATRX BAZ2A RSF1 BOD1L1 LSM14A ICE1 MTDH DEPDC1B TOP2B ESF1 RAD50 | 3.99e-07 | 978 | 57 | 14 | int:NAA40 |
| Interaction | H2BC12 interactions | 3.26e-06 | 322 | 57 | 8 | int:H2BC12 | |
| Interaction | SMC5 interactions | NELFE PARP1 ATRX BAZ2A RBM19 RSF1 BOD1L1 MPHOSPH8 ICE1 MTDH TOP2B ESF1 RAD50 | 3.27e-06 | 1000 | 57 | 13 | int:SMC5 |
| Interaction | H3-3A interactions | PARP1 ATRX KDM5A BAZ2A RSF1 CHD9 BOD1L1 MPHOSPH8 CHD1L TOP2B RAD50 | 6.72e-06 | 749 | 57 | 11 | int:H3-3A |
| Interaction | POLR1G interactions | 8.66e-06 | 489 | 57 | 9 | int:POLR1G | |
| Interaction | H3C3 interactions | 9.55e-06 | 495 | 57 | 9 | int:H3C3 | |
| Interaction | CBX3 interactions | 1.18e-05 | 646 | 57 | 10 | int:CBX3 | |
| Interaction | NPM1 interactions | NELFE PARP1 UTP18 NF1 RBM19 SYCP1 CPSF2 TRDN MTDH DDX27 TOP2B ESF1 RAD50 | 2.35e-05 | 1201 | 57 | 13 | int:NPM1 |
| Interaction | ENO1 interactions | NELFE FAM193B MYH11 FAM186A ATP6V1D SYCP1 MPHOSPH8 DIAPH3 RRM1 MTDH | 2.39e-05 | 701 | 57 | 10 | int:ENO1 |
| Interaction | NOP56 interactions | 2.92e-05 | 570 | 57 | 9 | int:NOP56 | |
| Interaction | SUPT16H interactions | 3.24e-05 | 442 | 57 | 8 | int:SUPT16H | |
| Interaction | CTCF interactions | 4.36e-05 | 461 | 57 | 8 | int:CTCF | |
| Interaction | YWHAH interactions | NELFE MYH11 NF1 ARHGEF28 MYCBP2 KDM5A CCDC18 BOD1L1 SH3RF3 DEPDC1B DOP1A MTSS2 | 4.83e-05 | 1102 | 57 | 12 | int:YWHAH |
| Interaction | XRCC6 interactions | NELFE PARP1 ATRX BAZ2A BOD1L1 ICE1 CHD1L MTDH TOP2B ESF1 RAD50 | 4.91e-05 | 928 | 57 | 11 | int:XRCC6 |
| Interaction | POLR1E interactions | 5.63e-05 | 350 | 57 | 7 | int:POLR1E | |
| Interaction | NUP43 interactions | 5.96e-05 | 625 | 57 | 9 | int:NUP43 | |
| Interaction | PYHIN1 interactions | 6.49e-05 | 358 | 57 | 7 | int:PYHIN1 | |
| Interaction | ATG16L1 interactions | NELFE FAM133B PARP1 UTP18 ARHGEF28 MYCBP2 MPHOSPH8 LSM14A DIAPH3 CPSF2 DEPDC1B TOP2B | 7.99e-05 | 1161 | 57 | 12 | int:ATG16L1 |
| Interaction | H2BC4 interactions | 8.91e-05 | 259 | 57 | 6 | int:H2BC4 | |
| Interaction | CENPA interactions | 8.97e-05 | 377 | 57 | 7 | int:CENPA | |
| Interaction | ZBTB21 interactions | 9.16e-05 | 161 | 57 | 5 | int:ZBTB21 | |
| Interaction | H1-2 interactions | 9.70e-05 | 666 | 57 | 9 | int:H1-2 | |
| Interaction | H2BC21 interactions | 1.35e-04 | 696 | 57 | 9 | int:H2BC21 | |
| Interaction | KCNA3 interactions | RALA PARP1 CHD9 BOD1L1 DIAPH3 RRM1 DEPDC1B LETM1 DOP1A RAD50 | 1.47e-04 | 871 | 57 | 10 | int:KCNA3 |
| Interaction | LINC02910 interactions | 1.51e-04 | 95 | 57 | 4 | int:LINC02910 | |
| Interaction | YWHAG interactions | NELFE NF1 ARHGEF28 MYCBP2 CCDC18 BOD1L1 RRM1 SH3RF3 DDX27 DEPDC1B DOP1A MTSS2 | 1.58e-04 | 1248 | 57 | 12 | int:YWHAG |
| Interaction | CIT interactions | MYH11 UTP18 RBM19 RSF1 DUOX2 BOD1L1 MPHOSPH8 CPSF2 RRM1 MTDH TOP2B ESF1 UTP14C | 1.62e-04 | 1450 | 57 | 13 | int:CIT |
| Interaction | SMARCA5 interactions | 1.62e-04 | 415 | 57 | 7 | int:SMARCA5 | |
| Interaction | CAMK2B interactions | 1.63e-04 | 182 | 57 | 5 | int:CAMK2B | |
| Interaction | IFI16 interactions | 1.64e-04 | 714 | 57 | 9 | int:IFI16 | |
| Interaction | HMGN4 interactions | 1.84e-04 | 100 | 57 | 4 | int:HMGN4 | |
| Interaction | SENP3 interactions | 2.02e-04 | 301 | 57 | 6 | int:SENP3 | |
| Interaction | H2BC8 interactions | 2.04e-04 | 576 | 57 | 8 | int:H2BC8 | |
| Interaction | RALBP1 interactions | 2.41e-04 | 198 | 57 | 5 | int:RALBP1 | |
| Interaction | SUMO2 interactions | 2.43e-04 | 591 | 57 | 8 | int:SUMO2 | |
| Interaction | NDC80 interactions | 2.45e-04 | 312 | 57 | 6 | int:NDC80 | |
| Interaction | H2AX interactions | 2.49e-04 | 593 | 57 | 8 | int:H2AX | |
| Interaction | ZNF330 interactions | 2.52e-04 | 446 | 57 | 7 | int:ZNF330 | |
| Interaction | PARP1 interactions | PARP1 UTP18 MYCBP2 RBM19 RSF1 CHD1L CPSF2 RRM1 DDX27 TOP2B ESF1 RAD50 | 2.60e-04 | 1316 | 57 | 12 | int:PARP1 |
| Interaction | CHD4 interactions | 2.68e-04 | 938 | 57 | 10 | int:CHD4 | |
| Interaction | H3C15 interactions | 2.96e-04 | 207 | 57 | 5 | int:H3C15 | |
| Interaction | RTKN interactions | 3.15e-04 | 115 | 57 | 4 | int:RTKN | |
| Interaction | SIRT6 interactions | 3.65e-04 | 628 | 57 | 8 | int:SIRT6 | |
| Interaction | NUCKS1 interactions | 3.91e-04 | 220 | 57 | 5 | int:NUCKS1 | |
| Interaction | HECTD1 interactions | FAM133B PARP1 UTP18 MYCBP2 LSM14A CPSF2 MTDH DDX27 TOP2B ESF1 | 3.92e-04 | 984 | 57 | 10 | int:HECTD1 |
| Interaction | FBL interactions | 4.10e-04 | 639 | 57 | 8 | int:FBL | |
| Interaction | HMGB1 interactions | 4.24e-04 | 486 | 57 | 7 | int:HMGB1 | |
| Interaction | ESAM interactions | 4.25e-04 | 11 | 57 | 2 | int:ESAM | |
| Interaction | DCLK1 interactions | 4.59e-04 | 127 | 57 | 4 | int:DCLK1 | |
| Interaction | EP300 interactions | NELFE PARP1 UTP18 RSF1 RRM1 MTDH DDX27 LETM1 TOP2B SEPTIN6 SMAD5 RAD50 | 4.60e-04 | 1401 | 57 | 12 | int:EP300 |
| Interaction | RHOA interactions | RALA PARP1 UTP18 NF1 ARHGEF28 DIAPH3 MTDH DDX27 DEPDC1B LETM1 TOP2B | 4.64e-04 | 1199 | 57 | 11 | int:RHOA |
| Interaction | DAXX interactions | 4.73e-04 | 353 | 57 | 6 | int:DAXX | |
| Interaction | RALGPS2 interactions | 4.80e-04 | 54 | 57 | 3 | int:RALGPS2 | |
| Interaction | MAST3 interactions | 4.87e-04 | 129 | 57 | 4 | int:MAST3 | |
| Interaction | H2AC17 interactions | 4.98e-04 | 232 | 57 | 5 | int:H2AC17 | |
| Interaction | SVIL interactions | 5.08e-04 | 233 | 57 | 5 | int:SVIL | |
| Interaction | CD274 interactions | 5.98e-04 | 369 | 57 | 6 | int:CD274 | |
| Interaction | SSRP1 interactions | 6.49e-04 | 685 | 57 | 8 | int:SSRP1 | |
| Interaction | AATF interactions | 6.59e-04 | 376 | 57 | 6 | int:AATF | |
| Interaction | ANKRD13D interactions | 6.87e-04 | 61 | 57 | 3 | int:ANKRD13D | |
| Cytoband | 5q31 | 4.06e-04 | 115 | 57 | 3 | 5q31 | |
| GeneFamily | I-BAR domain containing | 2.31e-05 | 5 | 28 | 2 | 1287 | |
| GeneFamily | PHD finger proteins | 3.57e-04 | 90 | 28 | 3 | 88 | |
| GeneFamily | RNA binding motif containing | 4.25e-03 | 213 | 28 | 3 | 725 | |
| GeneFamily | Ankyrin repeat domain containing | 6.06e-03 | 242 | 28 | 3 | 403 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | RALA MYCBP2 RSF1 MPHOSPH8 DIAPH3 CEP57 MTDH TOP2B ESF1 ENOX2 RAD50 | 1.44e-07 | 656 | 57 | 11 | M18979 |
| Coexpression | OSMAN_BLADDER_CANCER_UP | 2.45e-06 | 402 | 57 | 8 | M5275 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | PARP1 TBRG1 ATRX MYCBP2 KDM5A RSF1 BOD1L1 MPHOSPH8 LSM14A ICE1 MTDH TOP2B ZMYM5 SEPTIN6 | 2.69e-06 | 1492 | 57 | 14 | M40023 |
| Coexpression | TBK1.DF_DN | 2.84e-06 | 286 | 57 | 7 | M2864 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | 3.13e-06 | 721 | 57 | 10 | M10237 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 3.89e-06 | 300 | 57 | 7 | M8702 | |
| Coexpression | GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN | 4.67e-06 | 199 | 57 | 6 | M6648 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 1.94e-05 | 534 | 57 | 8 | MM1054 | |
| Coexpression | GSE11386_NAIVE_VS_MEMORY_BCELL_DN | 2.43e-05 | 158 | 57 | 5 | M372 | |
| Coexpression | GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_UP | 3.17e-05 | 167 | 57 | 5 | M365 | |
| Coexpression | GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_DN | 3.45e-05 | 170 | 57 | 5 | M6747 | |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 4.47e-05 | 90 | 57 | 4 | M39250 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | 5.09e-05 | 612 | 57 | 8 | M4772 | |
| Coexpression | GSE14308_TH1_VS_INDUCED_TREG_UP | 7.46e-05 | 200 | 57 | 5 | M3378 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 1.35e-04 | 523 | 57 | 7 | M12707 | |
| Coexpression | KAUFFMANN_DNA_REPAIR_GENES | 1.44e-04 | 230 | 57 | 5 | M11563 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | PARP1 UTP18 BAZ2A LSM14A ICE1 RRM1 CEP57 MTDH DDX27 TOP2B ENOX2 | 1.78e-04 | 1394 | 57 | 11 | M9585 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | 1.90e-04 | 946 | 57 | 9 | M39169 | |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP | 2.24e-04 | 568 | 57 | 7 | M4023 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 2.68e-04 | 143 | 57 | 4 | M9149 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | RALA ATRX MYCBP2 KDM5A CHD9 LSM14A ICE1 MTDH ESF1 MTSS2 RAD50 | 1.75e-07 | 564 | 55 | 11 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | UTP18 KDM5A BAZ2A CCDC18 SYCP1 CHD1L ANKRD12 DIAPH3 FAM228A ESF1 DOP1A RAD50 | 9.65e-07 | 820 | 55 | 12 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ATRX RSF1 CHD9 BOD1L1 MPHOSPH8 CPSF2 RRM1 CEP57 MTDH ZMYM5 ESF1 SMAD5 RAD50 | 1.45e-05 | 1257 | 55 | 13 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.50e-05 | 311 | 55 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 2.61e-05 | 469 | 55 | 8 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 3.12e-05 | 629 | 55 | 9 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.35e-05 | 258 | 55 | 6 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.33e-05 | 266 | 55 | 6 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | ATRX RSF1 CHD9 BOD1L1 MPHOSPH8 CPSF2 RRM1 CEP57 MTDH ZMYM5 ESF1 SMAD5 RAD50 | 6.88e-05 | 1459 | 55 | 13 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.20e-04 | 432 | 55 | 7 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.38e-04 | 595 | 55 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | 1.56e-04 | 776 | 55 | 9 | gudmap_developingGonad_e14.5_ ovary_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | 2.15e-04 | 810 | 55 | 9 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.16e-04 | 333 | 55 | 6 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | ATRX KDM5A CHD9 BOD1L1 MPHOSPH8 ZMYM5 ESF1 SMAD5 ENOX2 RAD50 | 3.47e-04 | 1060 | 55 | 10 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 4.27e-04 | 532 | 55 | 7 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | 4.49e-04 | 382 | 55 | 6 | gudmap_developingGonad_e14.5_ ovary_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#3_top-relative-expression-ranked_100 | 5.88e-04 | 14 | 55 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_100_k3 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | ATRX KDM5A RSF1 CCDC18 BOD1L1 MPHOSPH8 ANKRD12 DDX27 ESF1 RAD50 | 7.43e-14 | 197 | 57 | 10 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.68e-10 | 198 | 57 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 6.53e-09 | 199 | 57 | 7 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-07 | 182 | 57 | 6 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-07 | 182 | 57 | 6 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-07 | 185 | 57 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-07 | 194 | 57 | 6 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 2.09e-07 | 199 | 57 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 2.09e-07 | 199 | 57 | 6 | b2d7dea11207cca63d688f8051143850b29dbdf0 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.09e-07 | 199 | 57 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.16e-06 | 177 | 57 | 5 | 3081ce5fc66a1bb833719d6c0e0a6fc7115eeb91 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-06 | 182 | 57 | 5 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-06 | 184 | 57 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-06 | 192 | 57 | 5 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | cycling_basal_cell|World / shred by cell class for nasal brushing | 5.19e-06 | 196 | 57 | 5 | aa7bac70a2fe4a3cb28d89fa1a87c68c2ead1349 | |
| ToppCell | (3)_MNP-(3)_Macrophage_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.32e-06 | 197 | 57 | 5 | 048bc4f8fd5d4f394e2384700640f72042336597 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 5.46e-06 | 198 | 57 | 5 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 5.59e-06 | 199 | 57 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 5.59e-06 | 199 | 57 | 5 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 5.59e-06 | 199 | 57 | 5 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 5.59e-06 | 199 | 57 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.73e-06 | 200 | 57 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 2.95e-05 | 138 | 57 | 4 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.06e-05 | 166 | 57 | 4 | 9a341dc7b756252caeaac1e934384911c880a634 | |
| ToppCell | Dividing_Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 6.06e-05 | 166 | 57 | 4 | c503036f3c19ef186e1e62c9643c49dea3827f51 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.06e-05 | 166 | 57 | 4 | 390cf5e56b72fcaf3b8520930bd35a3e3e173711 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.20e-05 | 167 | 57 | 4 | 754e6412d3b9cc0b126e59593df2f5956b4712ef | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.50e-05 | 169 | 57 | 4 | a6a5b00912b653fad2ca7f096deaf35c9ef85e5b | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.50e-05 | 169 | 57 | 4 | 88aa2246ede582c2e11de63228d76f520889ecb3 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.50e-05 | 169 | 57 | 4 | 42a9b8c77d2a4d68b01e4db38f8a1af53c9c814f | |
| ToppCell | droplet-Fat-Mat-18m-Lymphocytic-lymphocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-05 | 172 | 57 | 4 | 226de1a5d4a360d3ae01b0235fea19521ec623a0 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.77e-05 | 177 | 57 | 4 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)|World / shred by cell type and Timepoint | 7.77e-05 | 177 | 57 | 4 | 05c57578142a6662f18b294d5cc11e6efd6b0f8e | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.47e-05 | 181 | 57 | 4 | 0c5bc1660b8fc1e905ab4230202862de5be46ebd | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.47e-05 | 181 | 57 | 4 | f83565f09dd971c5cad2704a4a86bca0accd955e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.47e-05 | 181 | 57 | 4 | 73b1b59810f60e3e39ca1d5073a5a0d4f5377e6e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 9.22e-05 | 185 | 57 | 4 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4/8-lo|blood / Manually curated celltypes from each tissue | 9.22e-05 | 185 | 57 | 4 | df85ff34b796b403f2d0741771e9592e03657f6a | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4/8-lo-Cycling_T|blood / Manually curated celltypes from each tissue | 9.81e-05 | 188 | 57 | 4 | 714ccbcf826f26d39757931a3b8abbd952f4cddc | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 191 | 57 | 4 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.04e-04 | 191 | 57 | 4 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 191 | 57 | 4 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | (3)_Macrophage_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.04e-04 | 191 | 57 | 4 | b42f0b89bb94fd43786ff50f1caeb3ebfbbb43fd | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 191 | 57 | 4 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.06e-04 | 192 | 57 | 4 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-04 | 193 | 57 | 4 | a332dfdcc48c405020014e644aa4d14fda98cc86 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-4|World / Primary Cells by Cluster | 1.09e-04 | 193 | 57 | 4 | 2eb6e4cff4fe3ce564c1581f6f7df4834895aaa9 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-04 | 193 | 57 | 4 | e45ce9cf8421512b57f157c24b64793b47b4ba4b | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-04 | 193 | 57 | 4 | b835d28de9daeec5213172c96f62b332cda53bb5 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.11e-04 | 194 | 57 | 4 | f64da5f62e29253d60b9546edf734ba5c17daae1 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-04 | 194 | 57 | 4 | 1a2090e997c70433d07f56bf7cb0a50c4151118c | |
| ToppCell | (1)_T_cells_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.11e-04 | 194 | 57 | 4 | 8f313071933451780309d2174ed27d8cdc734343 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.11e-04 | 194 | 57 | 4 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | (7)_Epithelial-J_(AT1-AT2_progenitors)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.13e-04 | 195 | 57 | 4 | 70e6b58c502a2abeb4e36bed179020c675468bd4 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-04 | 195 | 57 | 4 | 67670d16ddd5d5ab7bc2254df329f5a7b2581556 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.13e-04 | 195 | 57 | 4 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.13e-04 | 195 | 57 | 4 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.13e-04 | 195 | 57 | 4 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | BLOOD--(1)_Activated_T_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.13e-04 | 195 | 57 | 4 | 45515d5da8a8c8242eb70a1bea24fe44eca5407b | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-04 | 195 | 57 | 4 | 23dc2f8a3a038195a31feee7e3a51094a7a7c23e | |
| ToppCell | (4)_B_Hypermutation|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.13e-04 | 195 | 57 | 4 | 54d2acaff6be6b5604591bdbd7d769ac3e74f223 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 195 | 57 | 4 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 1.15e-04 | 196 | 57 | 4 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.15e-04 | 196 | 57 | 4 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | myeloid-pro-pDC|myeloid / Lineage and Cell class | 1.15e-04 | 196 | 57 | 4 | 70daf4fabb68aecc5cc9f03d6f6495dd29b74a16 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-Large_pre-B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.17e-04 | 197 | 57 | 4 | 7e0834b3947031bf244a10624dcf3f2095c79368 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-GC_B_(I)|GI_large-bowel / Manually curated celltypes from each tissue | 1.17e-04 | 197 | 57 | 4 | 80a0cfbd454409594effead7082586b06c2f411a | |
| ToppCell | Mild|World / Condition, Lineage, Cell class and cell subclass | 1.17e-04 | 197 | 57 | 4 | 476b0d0389f9fcd4614f6bb1f494281f467f6730 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.20e-04 | 198 | 57 | 4 | 5f465cf5c7493e32d9afe9e9d05757d0a95acc33 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.20e-04 | 198 | 57 | 4 | 77ce3fe1ab161c0faf8987e73a64ab61294b9255 | |
| ToppCell | (4)_B_cells-(4)_B_Hypermutation|(4)_B_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.20e-04 | 198 | 57 | 4 | 8be724a49b4c911d68c3e82fb75e96722d0eaa03 | |
| ToppCell | cycling_basal_cell|World / shred by cell class for bronchial biopsy | 1.20e-04 | 198 | 57 | 4 | d5306121a75c5eb37d62c353799a98e6ba5ab63f | |
| ToppCell | (0)_NK_cells-(0)_NK_Dividing|(0)_NK_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.20e-04 | 198 | 57 | 4 | d9cdbc7d420472cb1ffb36ad9c8e53a61b7dbdeb | |
| ToppCell | (3)_DC_Monocyte_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.20e-04 | 198 | 57 | 4 | e2b89f6d7c0007ccab62495cd543fe0e5513a9a4 | |
| ToppCell | cycling_basal_cell|World / shred by cell class for turbinate | 1.20e-04 | 198 | 57 | 4 | e86c1224f5b0890a50a25257628e90c790aae7cd | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-04 | 198 | 57 | 4 | 281fc2536cdc4c717b30de156e563c0e4baba99d | |
| ToppCell | (1)_T_cell_dividing|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.20e-04 | 198 | 57 | 4 | dac3a16e3a070a37f4d0ea37633c23fdc8a9c70a | |
| ToppCell | (0)_NK_dividing|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.20e-04 | 198 | 57 | 4 | c5336d9b802393d6fd6f8446ea4bb6befeb97bfd | |
| ToppCell | (0)_NK_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.20e-04 | 198 | 57 | 4 | 5ebb4965b723302152b42bfaf48bb77a57dd02c5 | |
| ToppCell | 15-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 1.22e-04 | 199 | 57 | 4 | 5c8b847b794b3e88722f5b841f2539a27251106c | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.22e-04 | 199 | 57 | 4 | ea75804c34989c99aab542e6d72617ed144819b6 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.22e-04 | 199 | 57 | 4 | 5478b78349b5d8d57f30bb650dcbd5fdb84283d6 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.22e-04 | 199 | 57 | 4 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.22e-04 | 199 | 57 | 4 | 713dfd8552635645db5e0b5721c64e5c9b4aa06c | |
| ToppCell | (2)_B_cell-(24)_B_cell_cycling|(2)_B_cell / shred on Cell_type and subtype | 1.22e-04 | 199 | 57 | 4 | d5a9a8a71c4de8cbcef947943f60838731bc640b | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.22e-04 | 199 | 57 | 4 | fe3b7d540a644dfc6beea171c809b4d1ba4e188f | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 1.22e-04 | 199 | 57 | 4 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | NS-critical-d_16-33-Lymphoid-NKT-proliferating|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.22e-04 | 199 | 57 | 4 | 31b144bb209c629e12156f4d9c9cec79baffffb9 | |
| ToppCell | (1)_T_cells-(1)_T_cell_dividing|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.22e-04 | 199 | 57 | 4 | 33afdd1b1b951b360ababf440bc556fd9e1c1db2 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.22e-04 | 199 | 57 | 4 | cdee798e3586e4e7a15de598239090a85752ea1e | |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.24e-04 | 200 | 57 | 4 | c888fd487990cad482a4ca47601cdebc0ca3f3ce | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-04 | 200 | 57 | 4 | cea58274efbe7f9e3c3ef9fbb768ebfb917e21d9 | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 1.24e-04 | 200 | 57 | 4 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-04 | 200 | 57 | 4 | 5f2fbd789cc16af411a01c3199583888b260ae91 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-04 | 200 | 57 | 4 | 63f9481059be608ddc9fe9c7a8f8503fce9755dd | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.24e-04 | 200 | 57 | 4 | 19a4213f180ac2d29625d140b602a93a74ab3fdd | |
| ToppCell | Biopsy_Control_(H.)-Immune-Proliferating_Macrophages|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.24e-04 | 200 | 57 | 4 | ce9fad55f779afd3d6c5a9c5a15e2d9f548b7c7e | |
| ToppCell | (0)_NK_cells-(0)_NK_dividing|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.24e-04 | 200 | 57 | 4 | 1a630bb327070ffcb111ec36bd8fd4be3627ca2a | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.24e-04 | 200 | 57 | 4 | 0fd9a8730b7dc461ddf4586899d363541e72d8ba | |
| ToppCell | (3)_MNP-(3)_DC_Monocyte_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.24e-04 | 200 | 57 | 4 | d94fe9bd6ee7c1fed14666f24de41bda014e299b | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 7.38e-06 | 191 | 56 | 6 | 6020_DN | |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; PC3; HT_HG-U133A | 9.07e-06 | 198 | 56 | 6 | 5878_DN | |
| Drug | testosterone enanthate | 1.03e-05 | 575 | 56 | 9 | ctd:C004648 | |
| Disease | intellectual developmental disorder with ocular anomalies and distinctive facial features (implicated_via_orthology) | 3.41e-06 | 2 | 55 | 2 | DOID:0081301 (implicated_via_orthology) | |
| Disease | Mental Retardation, Psychosocial | 1.33e-04 | 139 | 55 | 4 | C0025363 | |
| Disease | Profound Mental Retardation | 1.33e-04 | 139 | 55 | 4 | C0020796 | |
| Disease | Mental deficiency | 1.33e-04 | 139 | 55 | 4 | C0917816 | |
| Disease | intellectual disability (implicated_via_orthology) | 3.76e-04 | 75 | 55 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | malignant astrocytoma (is_marker_for) | 8.42e-04 | 23 | 55 | 2 | DOID:3069 (is_marker_for) | |
| Disease | blood chromium measurement | 1.08e-03 | 26 | 55 | 2 | EFO_0007579 | |
| Disease | Intellectual Disability | 1.46e-03 | 447 | 55 | 5 | C3714756 | |
| Disease | emphysema imaging measurement | 2.58e-03 | 146 | 55 | 3 | EFO_0007626 | |
| Disease | high grade glioma (is_implicated_in) | 2.80e-03 | 42 | 55 | 2 | DOID:3070 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ADKKQKRKEKKTADL | 141 | Q86W67 | |
| LEKEKLKKEAAKKLE | 396 | Q9P2I0 | |
| KSEKQREAELKKKKL | 61 | Q15327 | |
| ETKSLKQKEAKKKSK | 741 | Q9UIF9 | |
| EKQKLEKQKKELKAT | 426 | Q86XR8 | |
| EKQKKELKATKKTLD | 431 | Q86XR8 | |
| SKRSKNIKKKLKEEQ | 181 | Q8NEA5 | |
| TDAKLSNKEKKKKLK | 461 | Q8WUY9 | |
| KLARKKDDDKKKSSN | 1301 | Q5JWR5 | |
| EKKSKLEKNIKDDKS | 721 | Q6UB98 | |
| KKKIKELKFLDSKIA | 706 | Q9NSV4 | |
| KKRKTEDKEAKSGKL | 126 | Q96GQ7 | |
| EDSKEKNGKKKRKSL | 181 | P11233 | |
| KKKKVAGQLEKLKED | 116 | Q9Y4C8 | |
| KLKSTESELKKKEKR | 711 | Q92878 | |
| KEKDKDSKLEKALKA | 226 | P09874 | |
| KSKTKSKDAKDKEKL | 636 | Q8N1W1 | |
| ESLSDKIQKKKKKIL | 256 | Q9NUD7 | |
| EEEALQKKFNKLKKK | 11 | P18615 | |
| KKKEAELEKLKDDKL | 476 | Q16206 | |
| EKSLKSLKDKNKKLE | 121 | O95202 | |
| QKKLKESVKKEAAKD | 631 | Q9NRD8 | |
| KKKTQTKKEIDSKNL | 96 | Q9H501 | |
| DSKNLVEKKKETKKA | 106 | Q9H501 | |
| IKKKSSDTLKLQKKA | 136 | Q765P7 | |
| EIKKKSSDTLKLQKK | 136 | O43312 | |
| NKLKLKEDKLEKQEK | 316 | Q8ND56 | |
| KKLKLGADKSKELNK | 1536 | P29375 | |
| EKNLVKLAKCLKKEK | 606 | A2A3N6 | |
| LEKKVALSKKRKKDS | 566 | Q8NFC6 | |
| SKKIRDKTSKKKDEL | 1046 | P46100 | |
| DKDSKKTKTCSKLKE | 576 | Q3L8U1 | |
| SDAQKKKLEAKVKKL | 126 | Q9Y2F5 | |
| ESDSKDSLKKKKKSK | 151 | Q5BKY9 | |
| LEGNKEKFEKQLKKK | 746 | Q5T9S5 | |
| KLKKKEKEKAQLAAE | 501 | Q96PV7 | |
| EEGLKKIFLAAKKKK | 821 | Q86WJ1 | |
| SEEQKKKNRKKLSEK | 111 | Q86UE4 | |
| TSFLDEKKKQKKKIL | 181 | A6NE01 | |
| VTEKKNKKLKKASAE | 11 | Q9BRJ6 | |
| KKKDSKKSKANLLER | 996 | Q96T23 | |
| LSKKKKTKREQLSEK | 346 | Q9UKG4 | |
| DDLKKKKAKAGKLKD | 166 | Q99549 | |
| SKLSKDNLKKRLKEE | 171 | Q9Y5J1 | |
| ADASKKLLKKKKGDL | 1251 | Q02880 | |
| AVLKKKECEKENKKS | 3191 | O75592 | |
| QDEKKKLEDKKKSLD | 376 | Q14141 | |
| AEKAVDALVKKLKKK | 31 | Q99717 | |
| TKSLKQKDKKLKEIL | 1841 | P35749 | |
| KEEYKEKKSKLLLAK | 506 | Q5VWI1 | |
| EKKSKLLLAKEEFKK | 511 | Q5VWI1 | |
| KKGKAKKALKEFEQL | 256 | Q5TAP6 | |
| TLNKEKLKDKEKVSK | 751 | P23921 | |
| EKKSEKKEKKSGLLK | 711 | Q8TEJ3 | |
| AKENTATLKEKKDKK | 781 | Q15431 | |
| QEKKKILKEKSEKDL | 206 | Q9Y5K8 | |
| LLNKATVKEKKENKK | 1376 | P21359 | |
| FRLKKAQKDEDKKTK | 526 | Q9NZM6 | |
| KKAKTAEKSEEKTKK | 206 | Q13061 | |
| SKLKSDLKKNKAIDA | 636 | Q9UJ78 | |
| KEKGKENNKLEVLKK | 141 | Q3YBR2 | |
| ENNKLEVLKKTCKKK | 146 | Q3YBR2 |